|Quantity Discounts||1 - 9999|
|1 - 9999|
|1 - 9999|
In addition to the more commonly used drug repositioning strategies, drugmakers are seeking approval for additional patient populations or by changing the formulation from an immediate-release drug to extended release.
But consider this …
In the wake of last year’s Supreme Court ruling in KSR Int’l. v. Teleflex, which expanded the “obviousness” test, it’s more difficult to get patent protection for products that are similar to the original. Any company that attempts to develop a repositioning plan without a focus on patentability could result in disaster.
How can you determine which strategy offers the best chance for a high-dollar return — new formulation or new indications? Which is riskier? Should the repositioning be done in-house or should it be outsourced to a specialty firm?
Here’s how …
In this 90-minute Encore presentation, patent attorney Richard B. Smith will tell you how to put together an effective plan for repositioning your products, including case studies of successes and failures, the benefits and risks of outsourcing, and ways to ensure patent protection.
Sign up your entire team to listen in and discover:
Don’t give generic competition the opportunity to get its new drug on the market! Register now for this vital audioconference and gain a complete understanding of the successful strategies to implement to keep your drug on the market. Plus, you'll get an opportunity to ask your toughest questions during the Q&A session.
Richard B. Smith is a partner with the law firm Edwards Angell Palmer & Dodge and co-chair of the firm's Life Sciences practice group. He concentrates his practice on strategic business collaborations for biotechnology and biomedical device companies typically involving licensing, marketing, supply and co-promotion transactions. Richard also advises on corporate issues common to technology companies, including venture capital financing, mergers and acquisitions, and all business aspects of intellectual property law. He is a registered patent attorney whose practice includes obtaining and enforcing patent, copyright, trademark and trade secret protection.
After graduating from the Rensselaer Polytechnic Institute with an undergraduate degree in Biomedical Engineering and a master's degree in Electrical Engineering, Richard worked as an engineer for the Hewlett-Packard Company for nine years and was primarily involved with the design and manufacturing of cardiac ultrasound imaging equipment. He holds three patents related to his work at Hewlett-Packard.
|Date:||Sept. 1–19, 2008|
|Location:||Your office or conference room (no need to travel!)|
Gather your team for maximum benefit! Your investment is for one dial-in.
We accept American Express, Visa and MasterCard. Make checks payable to FDAnews.
Or, register by phone: toll free (888) 838-5578 (inside the U.S.) or +1 (703) 538-7600
Registrations may not be cancelled. Please contact customer service to make any substitutions.
Copyright ©2018. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing